PTC THERAPEUTICS, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

PTC THERAPEUTICS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $1.73 billion for the year ending 2025.

  • PTC THERAPEUTICS, INC. showed an increase of +114.5% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from PTC THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), PTC THERAPEUTICS, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 553.7%.
  • Historical annual values: Fiscal year 2025: $1.73 billion | Fiscal year 2024: $806.78 million | Fiscal year 2023: $937.82 million | Fiscal year 2022: $698.80 million | Fiscal year 2021: $538.59 million | Fiscal year 2020: $380.77 million | Fiscal year 2019: $306.98 million | Fiscal year 2018: $264.73 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: